EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma


Auris, Nasus, Larynx 41(2): 201-206
RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma
Several human tumor tissues show an aberrant expression and activation of recepteur d'origine nantais (RON). In this paper, we investigate the expression of RON in human laryngeal squamous cell carcinoma (SCC) and evaluate whether RON affects the tumor cell progression in human laryngeal SCC cell line. Immunohistochemistry was used to assess RON expression in human laryngeal SCC. To evaluate the impact of RON knockdown, the cell invasion assay and cell migration assay using small-interfering RNA were performed. The expression of RON protein was dominantly observed in laryngeal SCC tissues relative to adjacent normal mucosa in all cases. Knockdown of RON resulted in significantly reduced cell invasion in human laryngeal SCC cells. Cell migration showed a marked decrease in RON knockdown laryngeal SCC cells compared to the negative control laryngeal SCC cells. Laryngeal SCC cell migration was enhanced by incubation with macrophage stimulating protein (MSP). RON is highly expressed in human laryngeal SCC. We suggest that RON plays an important role in invasion, and metastasis of laryngeal SCC.


Accession: 055338211

PMID: 24287326

DOI: 10.1016/j.anl.2013.10.014



Related references

Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer. Head & Neck 35(8): 1106-1113, 2014

Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer. Oncology Reports 35(6): 3331-3340, 2016

Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients. Gynecologic Oncology 111(2): 237-243, 2008

MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais. International Journal of Molecular Sciences 17(10): -, 2016

EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells. International Journal of Oncology 42(3): 1120-1126, 2013

Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis. American Journal of Pathology 181(5): 1773-1781, 2013

Association of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma. International Journal of Clinical and Experimental Medicine 8(5): 7116-7124, 2015

Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells. Journal of Biological Chemistry 284(21): 14001-14010, 2009

Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response-1 in gastric cancer cells. Journal of Cellular Biochemistry 113(4): 1217-1223, 2012

Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer. International Journal of Molecular Medicine 31(5): 1248-1254, 2013